Exor NV
Exor announces the launch of a Tender Offer to repurchase up to €1 billion in ordinary shares
Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal value of EUR 0.01 each in the share capital of Exor N.V. (each an “Ordinary Share”, and together the “Ordinary Shares”), executed via a reverse “Dutch auction”, for an aggregate consideration up to (and including) €1 billion to Qualifying Shareholders (as defined below) (the “Tender Offer”).
Exor delivers 9% Nav Per Share growth in 2024 - Launch of a €1 billion Share Buyback Program with Tender Offer at up to 10% premium
- NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%
- Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare
- Ordinary dividend to be distributed of approximately €100 million, subject to AGM approval
- Launch of a new €1 billion share buyback program in the form of a Tender Offer starting 27 March 2025 at
Exor N.V. publishes its 2025 Corporate Calendar
EXOR N.V. announced today the following Corporate Calendar for 2025:
• 26 March 2025: Board of Directors Meeting for the approval of the Company’s 2024 Annual Report
• 22 May 2025: Annual General Meeting of Shareholders for the adoption of the Company’s 2024 Financial Statements
• 17 September 2025: Board of Directors Meeting for the approval of the Company’s 2025 Half-Year Financial Report